Marta Estevez-Alvarez

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.

Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.

Journal: Medical sciences (Basel, Switzerland)

Published: January 08, 2026

The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.

The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.

Journal: eLife

Published: February 18, 2025

Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.

Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities.

Journal: Gerontology

Published: June 27, 2021

Comparison between Aptima® assays (Hologic) and the CoBAS® 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium.

Comparison between Aptima® assays (Hologic) and the CoBAS® 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: November 08, 2020

Detection of sexually transmitted disease-causing pathogens from direct clinical specimens with the multiplex PCR-based STD Direct Flow Chip Kit.

Detection of sexually transmitted disease-causing pathogens from direct clinical specimens with the multiplex PCR-based STD Direct Flow Chip Kit.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: June 23, 2019

A safe an easy method for building consensus HIV sequences from 454 massively parallel sequencing data.

A safe an easy method for building consensus HIV sequences from 454 massively parallel sequencing data.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: February 29, 2016

Microbiological diagnosis of human immunodeficiency virus infection

Microbiological diagnosis of human immunodeficiency virus infection

Journal: Enfermedades infecciosas y microbiologia clinica

Published: June 30, 2014

Study of human immunodeficiency virus transmission chains in Andalusia: analysis from baseline antiretroviral resistance sequences

Study of human immunodeficiency virus transmission chains in Andalusia: analysis from baseline antiretroviral resistance sequences

Journal: Enfermedades infecciosas y microbiologia clinica

Published: June 03, 2014

Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance

Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance

Journal: Enfermedades infecciosas y microbiologia clinica

Published: March 05, 2013

Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter.

Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter.

Journal: Journal of clinical microbiology

Published: February 08, 2013

Low prevalence of hepatitis B virus primary drug resistance in Southern Spain

Low prevalence of hepatitis B virus primary drug resistance in Southern Spain

Journal: Enfermedades infecciosas y microbiologia clinica

Published: June 19, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026